Interleukin-23 receptor single nucleotide polymorphisms in ulcerative colitis. A study in Iranian populations

Podolsky, 2002, Inflammatory bowel disease, N Engl J Med, 347, 417, 10.1056/NEJMra020831

Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063

Sartor, 2006, Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis, Nat Clin Pract Gastroenterol Hepatol, 3, 390, 10.1038/ncpgasthep0528

Xavier, 2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427, 10.1038/nature06005

Vermeire, 2005, Current status of genetics research in inflammatory bowel disease, Genes Immun, 6, 637, 10.1038/sj.gene.6364257

Orholm, 2000, Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study, Scand J Gastroenterol, 35, 1075, 10.1080/003655200451207

Ogura, 2001, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, 411, 603, 10.1038/35079114

Peltekova, 2004, Functional variants of OCTN cation transporter genes are associated with Crohn disease, Nat Genet, 36, 471, 10.1038/ng1339

Arseneau, 2007, Innate and adaptive immune responses related to IBD pathogenesis, Curr Gastroenterol Rep, 9, 508, 10.1007/s11894-007-0067-3

Fiocchi, 1998, Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology, 115, 182, 10.1016/S0016-5085(98)70381-6

Glas, 2007, rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants, PloS one, 2, e819, 10.1371/journal.pone.0000819

Fisher, 2008, Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease, Nat Genet, 40, 710, 10.1038/ng.145

Hayatbakhsh, 2012, IL-23 receptor gene rs7517847 and rs1004819 SNPs in ulcerative colitis, Iran J Immunol, 9, 128

Bouma, 2003, The immunological and genetic basis of inflammatory bowel disease, Nat Rev Immunol, 3, 521, 10.1038/nri1132

Veldhoen, 2006, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001

Duerr, 2006, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, Science, 314, 1461, 10.1126/science.1135245

Lennard-Jones, 1989, Classification of inflammatory bowel disease, Scand J Gastroenterol Suppl, 170, 2, 10.3109/00365528909091339

Nasiri, 2005, F.R. modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent, J Clin Lab Anal, 19, 229, 10.1002/jcla.20083

Éric Toussirot, 2013, Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement, Patient Prefer Adherence, 7, 369, 10.2147/PPA.S33162

Naser, 2012, Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis, World J Gastroenterol, 18, 412, 10.3748/wjg.v18.i5.412

Beadling, 2006, Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27, Arch Immunol Ther Exp (Warsz), 54, 15, 10.1007/s00005-006-0002-6

Latiano, 2008, Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy, World J Gastroenterol, 14, 4643, 10.3748/wjg.14.4643

Zhang, 2006, Critical role of IL-17 receptor signaling in acute TNBS-induced colitis, Inflamm Bowel Dis, 12, 382, 10.1097/01.MIB.0000218764.06959.91

Franke, 2010, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci, Nat Genet, 42, 1118, 10.1038/ng.717

Ferguson, 2010, IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population, Gastroenterol Res Pract, 539461

Illes, 2008, 3’UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis, Neurosci Lett, 431, 36, 10.1016/j.neulet.2007.11.015

Song, 2012, Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis, Mol Biol Rep, 39, 10655, 10.1007/s11033-012-1955-7

Hollis-Moffatt, 2009, Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis, Ann Rheum Dis, 68, 1340, 10.1136/ard.2008.090142

Brown, 2008, Breakthroughs in genetic studies of ankylosing spondylitis, Rheumatology (Oxford), 47, 132, 10.1093/rheumatology/kem269

Sands, 2001, Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study, Inflamm Bowel Dis, 7, 83, 10.1097/00054725-200105000-00001

Probert, 2003, Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial, Gut, 52, 998, 10.1136/gut.52.7.998

Jurgens, 2010, Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis, Am J Gastroenterol, 105, 1811, 10.1038/ajg.2010.95

Sandborn, 2008, A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease, Gastroenterology, 135, 1130, 10.1053/j.gastro.2008.07.014